386 related articles for article (PubMed ID: 11840595)
1. Comparative study of anti-PGL-1, anti-35 kDa and anti-lipoarabinomannan assays for serodiagnosis of leprosy.
Jayapal V; Selvibai G; Mahalakshmi K; Pushkala ; Regunath K; Subramanian S
Indian J Lepr; 2001; 73(3):229-37. PubMed ID: 11840595
[TBL] [Abstract][Full Text] [Related]
2. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
[TBL] [Abstract][Full Text] [Related]
3. Low predictive value of PGL-I serology for the early diagnosis of leprosy in family contacts: results of a 10-year prospective field study in French Polynesia.
Chanteau S; Glaziou P; Plichart C; Luquiaud P; Plichart R; Faucher JF; Cartel JL
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):533-41. PubMed ID: 8151183
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients.
Parkash O; Kumar A; Nigam A; Franken KL; Ottenhoff TH
Scand J Immunol; 2006 Oct; 64(4):450-5. PubMed ID: 16970689
[TBL] [Abstract][Full Text] [Related]
5. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
[TBL] [Abstract][Full Text] [Related]
6. IgG subclass recognition pattern in leprosy: recognition of M. leprae antigens by IgG1 and IgG3 antibodies is distinct across the disease spectrum.
Kifayet A; Hussain R
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):69-78. PubMed ID: 8627117
[TBL] [Abstract][Full Text] [Related]
7. Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts.
Chujor CS; Bernheimer H; Levis WR; Schwerer B
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):441-9. PubMed ID: 1890368
[TBL] [Abstract][Full Text] [Related]
8. A serologic study of naturally acquired leprosy in chimpanzees.
Gormus BJ; Xu KY; Alford PL; Lee DR; Hubbard GB; Eichberg JW; Meyers WM
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):450-7. PubMed ID: 1890369
[TBL] [Abstract][Full Text] [Related]
9. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG.
Vikerfors T; Olcén P; Wiker H; Watson JD
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188
[TBL] [Abstract][Full Text] [Related]
10. Serum antibodies to defined carbohydrate antigens during the course of treated leprosy.
Gelber RH; Li F; Cho SN; Byrd S; Rajagopalan K; Brennan PJ
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):744-51. PubMed ID: 2681457
[TBL] [Abstract][Full Text] [Related]
11. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.
Stefani MM; Martelli CM; Morais-Neto OL; Martelli P; Costa MB; de Andrade AL
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):356-64. PubMed ID: 9934362
[TBL] [Abstract][Full Text] [Related]
12. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
Mohanty KK; Joshi B; Katoch K; Sengupta U
Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
[TBL] [Abstract][Full Text] [Related]
13. Sero-immunoreactivity of cloned protein antigens of Mycobacterium leprae.
Khan MB; Deshpande RG; Davidson SK; Navalkar RG
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):195-200. PubMed ID: 1522362
[TBL] [Abstract][Full Text] [Related]
14. Quantitative relationship between anti-PGL-I-specific antibody levels and the lepromin reaction.
David HL; Maroja M F; Cruaud P
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):332-4. PubMed ID: 2071994
[No Abstract] [Full Text] [Related]
15. The value of IgM antibodies to PGL-I in the diagnosis of leprosy.
Lefford MJ; Hunegnaw M; Siwik E
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):432-40. PubMed ID: 1890367
[TBL] [Abstract][Full Text] [Related]
16. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions.
Verhagen C; Faber W; Klatser P; Buffing A; Naafs B; Das P
Am J Pathol; 1999 Jun; 154(6):1793-804. PubMed ID: 10362804
[TBL] [Abstract][Full Text] [Related]
17. Serological monitoring of the response to chemotherapy in leprosy patients.
Roche PW; Britton WJ; Failbus SS; Neupane KD; Theuvenet WJ
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):35-43. PubMed ID: 8326179
[TBL] [Abstract][Full Text] [Related]
18. Utility of gelatin particle agglutination test (MLPA) for rapid serodiagnosis of leprosy in a hyperendemic area.
Reddy BS; Badrinath S; Shantaraman R; Harish BN; Sheriff MO; Rao RS; Garg BR
Indian J Lepr; 1992; 64(4):469-73. PubMed ID: 1308521
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of enzyme immunoassays based on synthetic glycoconjugates and phenolic glycolipid-I for immunodiagnosis of leprosy.
Moudgil KD; Mishra R; Talwar GP
Indian J Lepr; 1990; 62(1):60-5. PubMed ID: 2193062
[TBL] [Abstract][Full Text] [Related]
20. Is PGL-1 also present in Leishmania donovani promastigotes?
Gupta PN; Pal NK
Indian J Lepr; 1998; 70(2):161-4. PubMed ID: 9724851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
